Literature DB >> 27233502

Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.

Su-Tze Chou1, Shih-Ting Tseng2,3.   

Abstract

BACKGROUND: Epidemiological studies show that 5-40 % of type 2 diabetes (T2DM) patients have diabetic nephropathy, and oxidative stress is one of several underlying mechanisms. We investigated associations between oxidative stress markers and severity of diabetic nephropathy.
METHODS: Fifty-nine T2DM patients from the endocrinology outpatient department were included, and their levels of oxidative stress markers were measured. Three groups were determined by their urine albumin-to-creatinine ratio (UACR): group A (UACR < 30 mg/g, n = 22); group B (30 ≤ UACR < 300 mg/g, n = 22); and group C (UACR ≥ 300 mg/g, n = 15).
RESULTS: Vitamin C levels correlated negatively and moderately with serum creatinine (γ = -0.459, p < 0.001), urine albumin (γ s = -0.458, p = 0.001) and UACR (γ s = -0.408, p = 0.001), but only weakly with hydroxy-2-deoxyguanosine (8-OHdG) and estimated glomerular filtration rate (eGFR). Vitamin C levels decreased as 8-OHdG, serum creatinine, albumin and UACR increased. T2DM patients with more severe diabetic nephropathy had lower vitamin C levels.
CONCLUSION: Our results identified several oxidative stress markers that may be clinically important in diabetic nephropathy. Studies with larger sample sizes should be undertaken to confirm these findings.

Entities:  

Keywords:  Antioxidant; Diabetes mellitus; Diabetic nephropathy; Oxidative stress; Vitamin C

Mesh:

Substances:

Year:  2016        PMID: 27233502     DOI: 10.1007/s10157-016-1283-7

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  32 in total

1.  (9) Microvascular complications and foot care.

Authors: 
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

2.  Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury.

Authors:  Daisuke Kadowaki; Makoto Anraku; Moe Sakaya; Sumio Hirata; Toru Maruyama; Masaki Otagiri
Journal:  Clin Exp Nephrol       Date:  2015-04-23       Impact factor: 2.801

3.  Comparison of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy.

Authors:  Muhittin Serdar; Erdim Sertoglu; Metin Uyanik; Serkan Tapan; Kadir Akin; Cumhur Bilgi; Ismail Kurt
Journal:  Free Radic Res       Date:  2012-08-08

4.  Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.

Authors:  G W Xu; Q H Yao; Q F Weng; B L Su; X Zhang; J H Xiong
Journal:  J Pharm Biomed Anal       Date:  2004-09-21       Impact factor: 3.935

5.  Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients.

Authors:  Vadde Ramakrishna; Rama Jailkhani
Journal:  Acta Diabetol       Date:  2007-10-09       Impact factor: 4.280

6.  The oxidative stress status in diabetes mellitus and diabetic nephropathy.

Authors:  Hong-zhi Pan; Lin Zhang; Mei-yi Guo; Hong Sui; Hui Li; Wei-hua Wu; Nai-qiang Qu; Mei-hua Liang; Dong Chang
Journal:  Acta Diabetol       Date:  2009-05-28       Impact factor: 4.280

Review 7.  "Anti-inflammatory" drugs and their effects on type 2 diabetes.

Authors:  Kevin A Deans; Naveed Sattar
Journal:  Diabetes Technol Ther       Date:  2006-02       Impact factor: 6.118

8.  Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats.

Authors:  S Stackhouse; P L Miller; S K Park; T W Meyer
Journal:  Diabetes       Date:  1990-08       Impact factor: 9.461

Review 9.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

10.  Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus.

Authors:  Ryoichi Takayanagi; Toyoshi Inoguchi; Keizo Ohnaka
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

View more
  11 in total

1.  Antioxidative Stress and Anti-Inflammatory Activity of Fucoidan Nanoparticles against Nephropathy of Streptozotocin-Induced Diabetes in Rats.

Authors:  Giftania Wardani; Jusak Nugraha; Mohd Rais Mustafa; Sri Agus Sudjarwo
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-31       Impact factor: 2.650

2.  The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes.

Authors:  Suvanjaa Sivalingam; Emil List Larsen; Daniel H van Raalte; Marcel H A Muskiet; Mark M Smits; Lennart Tonneijck; Jaap A Joles; Bernt Johan von Scholten; Emilie Hein Zobel; Frederik Persson; Trine Henriksen; Lars Jorge Diaz; Tine W Hansen; Henrik Enghusen Poulsen; Peter Rossing
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

3.  Anti-Diabetic Nephropathy Activities of Polysaccharides Obtained from Termitornyces albuminosus via Regulation of NF-κB Signaling in db/db Mice.

Authors:  Chang Yang; Qi Feng; Huan Liao; Xinlei Yu; Yang Liu; Di Wang
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

4.  The Hypoglycemic and Renal Protection Properties of Crocin via Oxidative Stress-Regulated NF-κB Signaling in db/db Mice.

Authors:  Ye Qiu; Xue Jiang; Danping Liu; Zichun Deng; Weiwei Hu; Zhiping Li; Yuxin Li
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

5.  10-Dehydrogingerdione Attenuates Tramadol-Induced Nephrotoxicity by Modulating Renal Oxidative Stress, Inflammation and Apoptosis in Experimental Rats: Role of HO-1 Activation and TLR4/NF-κB/ERK Inhibition.

Authors:  Gehad M Elnagar; Mohamed M Elseweidy; Yasmin K Mahmoud; Nesreen M I M Elkomy; Ziyad M Althafar; Sultan F Alnomasy; Naif A Al-Gabri; Mohamed Shawky
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

6.  Inhibition of Endoplasmic Reticulum Stress Improves Acetylcholine-Mediated Relaxation in the Aorta of Type-2 Diabetic Rats.

Authors:  Sagir Mustapha; Ahmad Khusairi Azemi; Wan Amir Nizam Wan Ahmad; Aida Hanum Ghulam Rasool; Mohd Rais Mustafa; Siti Safiah Mokhtar
Journal:  Molecules       Date:  2022-08-11       Impact factor: 4.927

7.  Vitamin D Supplementation Could Enhance the Effectiveness of Glibenclamide in Treating Diabetes and Preventing Diabetic Nephropathy: A Biochemical, Histological and Immunohistochemical Study.

Authors:  Tarek Atia; Mohammad Zahidul Iqbal; Hassan Fathy Ahmed; Hader I Sakr; M H Abdelzaher; Deaa Fekri Morsi; Mostafa E Metawee
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

8.  PCB118 Induces Inflammation of Islet Beta Cells via Activating ROS-NLRP3 Inflammasome Signaling.

Authors:  Chunxia Jiang; Yuping Wang; Man Guo; Yang Long; Jiao Chen; Fang Fan; Shi Tang; Yong Xu
Journal:  Biomed Res Int       Date:  2021-05-17       Impact factor: 3.411

9.  Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation.

Authors:  Yudi Zhang; Chunhe Tao; Chen Xuan; Junyan Jiang; Wenfu Cao
Journal:  Oxid Med Cell Longev       Date:  2020-08-12       Impact factor: 6.543

10.  Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial-to-Mesenchymal Transition in db/db Mice.

Authors:  Qilin Zhang; Xiaocui Liu; Mitchell A Sullivan; Chen Shi; Bin Deng
Journal:  Oxid Med Cell Longev       Date:  2021-08-31       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.